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Large population studies suggest that excessive dietary sodium, principally as the chloride salt, is an important 
trigger for hypertension.1,2 The mechanisms for this relation-
ship are still debated.3,4 In the classical paradigm, increased salt 
intake leads to increased sodium accumulation in the extracellu-
lar space with a corresponding increase in extracellular volume, 
which can be partly counterbalanced by pressure natriuresis.5 
However, more recent studies looking at sodium balance in 
humans have shown that large amounts of sodium can accumu-
late without commensurate water retention.6–8 These observa-
tions oppose the traditional view that sodium balance functions 
as a 2-compartment model, supporting the existence of nonos-
motic sodium retention in a third compartment. In support of 
this, studies in rat models have shown that the skin is capable 
of osmotically inactive Na+ storage, via glycosaminoglycans 
(glycocalyx), serving as an important mechanism for buffering 
volume and blood pressure (BP) changes with salt intake.9–11 
High-salt intake in rats also stimulates tonicity-responsive 
enhancer binding protein secretion by mononuclear phagocyte 
system cells, which mediates VEGF-C (vascular endothelial 
growth factor C) expression. This results in enhanced intersti-
tial lymphatic drainage and increased expression of endothelial 
nitric oxide (NO) synthase, which buffers the hemodynamic 
response to salt loading.10,11 However, the relevance of these 
mechanisms in humans is unclear. In humans, the skin is the 
largest organ in the body, constituting 6% of body weight and 
receiving 20% to 30% of the cardiac output under normal con-
ditions and up to 60% in erythroderma and other pathological 
conditions, and its role in BP control is of current interest.12,13 
Recent 23Na magnetic resonance imaging (MRI) studies in 
humans show a direct relationship between skin Na+ and BP, 
as well as age and sex differences in the capacity to store skin 
Na+.14,15 Although MRI data were confirmed by direct ashing 
of human cadaveric samples, they have not yet been confirmed 
by direct chemical analysis of skin electrolytes in humans.16 
Moreover, 23Na MRI has not been used to measure changes in 
skin Na+ with dietary salt modulation. We hypothesized that 
the degree of change in skin sodium would relate to the BP 
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change seen with dietary salt loading. We tested this hypoth-
esis in a group of young healthy adults in whom we studied 
change in skin Na+ with increased dietary salt intake, by direct 
chemical measurements. We also sought to study the correla-




Participants were healthy individuals aged between 18 and  50 years 
and recruited by advertisement. Exclusion criteria included hyperten-
sion (sustained BP >140/90 mm Hg), current use of antihypertensive 
drugs, diuretics, salt supplements, renal impairment, or pregnancy. 
All participants gave informed consent before study participation. 
Ethical approval for the study was obtained from a National Research 
Ethics Committee (REC Reference: 11/H0304/003) and was per-
formed according to Good Clinical Practice and according to the 
principles of the Declaration of Helsinki.
Study Protocol
We conducted a 4-week single-center, double-blind, randomized, 
cross-over study as depicted in Figure S1 in the online-only Data 
Supplement. Volunteers were screened and placed on a 4-g low-salt 
diet (equivalent to 70 mmol of sodium/d) at visit 1 to standardize the 
background sodium intake. Participants were outpatients and given a 
printed booklet provided by practicing dietitians on how to maintain a 
low-salt diet, with email and telephone advice offered throughout the 
duration of the study. Baseline salt consumption was assessed with 
24-hour urinary sodium excretion (UNaV) up to 3 days after visit 1. 
Participants with high baseline salt intakes were given further advice 
on dietary salt restriction. After a 1-week run-in period on a low-
sodium diet, participants received slow sodium (200 mmol/d for 7 
days) or placebo tablets during weeks 2 and 4 in random order. Study 
compliance was assessed by 24-hour UNaV within 48 hours of visits 
2, 3, and 4 with participants and investigators blinded to the results. 
Medication compliance was assessed by participants returning used 
tablet bottles. Each participant was seen at approximately the same 
time at each study visit in a temperature-controlled room. Participants 
were required to refrain from caffeine, alcohol, strenuous exercise, 
and the application of moisturizer or fake tan to their lower back for 
6 hours before study visits. At each visit, weight was measured using 
the same calibrated scales, with 1 layer of clothing on no shoes, and 
seated brachial BP was recorded after a minimum of 5 minutes rest. 
After a further 10 minutes supine rest, brachial BP, cardiac output, 
stroke volume, pulse wave analysis, and aortic pulse wave velocity 
were taken. Ambulatory BP monitoring was recorded with 24-hour 
UNaV collections within 48 hours of visits 2, 3, and 4. At visits 2 and 
4, after hemodynamic measurements, a skin biopsy was taken. The 
skin biopsies were taken from the lower back to minimize any impact 
of scarring. The first biopsy was done on the right and the second 
on the left in a symmetrical position. Skin was analyzed by induc-
tively coupled plasma optical emission spectrometry (ICP-OES) to 
determine Na+ and K+ concentrations in milligrams per gram of wet 
skin. ICP-OES is a highly sensitive analytic tool capable of simul-
taneous multielemental determinations down to the subparts-per-
billion level.17 We summarize the technique in the online-only Data 
Supplement (Figures S2 and S3), together with the specific methods 
for hemodynamic and biochemical measurements and skin biopsies.
Statistical Analysis
The primary outcome measure was change in skin sodium concentra-
tion between the placebo and slow sodium phases. Because of tech-
nical limitations of drying small tissue samples, encountered when 
validating the ICP-OES, we had to change our measure from absolute 
dry Na+ to Na+:K+ ratio. As published data available on changes in 
skin sodium concentration in response to salt loading in humans were 
lacking, the initial sample size of 48 was based on other salt loading 
studies of a similar design, with a planned interim analysis to assess 
effect size and power. Normally distributed data are presented as 
mean±SEM and non-normal data as median and interquartile range. 
Tests for normality were performed using the Shapiro–Wilk test. 
Student paired t tests were applied to paired observations after pla-
cebo and slow sodium for normally distributed data and the Wilcoxon 
signed-rank test for non-normally distributed data. Independent 
samples t tests were applied to unpaired observations (normally dis-
tributed data) and the Mann–Whitney test (non-normally distributed 
data). Correlation coefficients between skin Na+:K+ and putative 
parameters, such as age, sex, body mass index, body surface area, and 
hemodynamic variables, were calculated using Pearson method (nor-
mally distributed variables) and Spearman method (non-normally dis-
tributed variables). We then performed multiple regression analysis to 
examine the parameters that independently influence skin Na+:K+. In 
analyzing the data, it became apparent that that skin Na+:K+ differed 
by sex, and a post hoc sex-specific analysis was therefore under-
taken. The presence of carry-over effect was checked using univariate 
ANOVA. A probability of <5% was used to reject the null hypothesis. 
Statistical analysis was performed with SPSS software (version 23.0).
Results
In all, 24 men and 24 women completed the study (mean age 
of 30±2 years; range, 18–49 years). Baseline characteristics 
are shown in Table S1. All women were pre-menopausal, 
and 10 were using an oral contraceptive pill or contraceptive 
implant. Our study population had a lower baseline sodium 
intake compared with the current average intake in England 
(≈130 mmol/d).18 The primary end point was the change in 
skin Na+:K+ between placebo and slow sodium phases. There 
was an increase in skin Na+:K+ between placebo and slow 
sodium phases (2.91±0.08 to 3.12±0.09; P=0.01; Figure 1A). 
In multiple regression analysis, including age, body mass 
index, clinic mean arterial pressure, and sex, only sex 
remained independently associated with skin Na+:K+ values 
(R2=0.316; P<0.001). This was primarily because in women, 
skin K+ was lower and the Na+:K+ ratio was consequently 
higher. Therefore, subsequent analyses were sex specific. 
Skin Na+, K+, and Na+:K+ values are presented in Table 1 and 
Figure 1. Men showed a significant increase in skin Na+:K+ of 
11.2% (P=0.008) from placebo to slow sodium phases while 
women showed nonsignificant increase of 4.0% (P=0.31). 
However, there was no significant difference between sexes on 
formal testing (repeated measures ANOVA P=0.31). Neither 
sex showed a significant change in skin K+ with a change in 
salt intake, in keeping with previous animal studies.19,20 No 
evidence of carry-over effect was seen for skin Na+:K+ or skin 
Na+ for either sex using univariate ANOVA with order of treat-
ment (placebo or slow sodium) as a fixed factor (P=0.68).
Hemodynamic responses to placebo versus slow sodium 
are shown in Table 2. In men, there were no differences in 
hemodynamics after salt loading while women had higher 
24-hour systolic BP, 24-hour mean arterial pressure, daytime 
systolic BP, nighttime systolic BP, diastolic BP, and mean 
arterial pressure. Only women had an increase in body weight 
post-slow sodium (63.5±1.6 versus 64.2±1.6 kg; P=0.01). 
Baseline characteristics and hemodynamic responses to salt 
loading were similar in women with and without contra-
ceptive use (Tables S3 and S4). Differences in biochemical 
responses to placebo versus slow sodium are shown in Table 3. 
As expected, slow sodium increased 24-hour UNaV, serum 
Na+, and Cl− and suppressed plasma renin and aldosterone. 
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There were no significant changes in plasma VEGF-C levels 
or sFLT-4 (soluble fms-like tyrosine kinase 4, a soluble recep-
tor for VEGF-C) between placebo and slow sodium in either 
sex or in the whole study population.
Univariate analyses revealed significant correlations 
between skin Na+:K+ and hemodynamic variables in men only 
as shown in Figure 2. Skin Na+:K+ correlated positively with 
supine mean arterial pressure post-placebo (r=0.53; P<0.01) 
and post-slow sodium (r=0.51; P=0.01). We observed that 
skin Na+:K+ was negatively correlated with stroke volume 
and positively correlated with peripheral vascular resistance 
(PVR) post-placebo and slow sodium. Plasma VEGF-C, 
after logarithmic transformation, showed a positive correla-
tion with skin Na+:K+ post-slow sodium (r=0.51; P=0.01) but 
not placebo (r=0.06; P=0.79; Figure 3). All correlations were 
independent of age and body mass index on multiple regres-
sion analysis. Correlations between hemodynamic parameters 
and skin Na+:K+ in women and urine Na+:K+ are shown in 
Figure S6 and Table S5, respectively.
Discussion
The main findings of this study are that skin sodium increases 
with dietary salt loading, and this may be influenced by sex. The 
dietary salt load we used (200 mmol Na+ for 7 days) is within 
the normal daily intakes of many individuals in urban societies 
and thus would be clinically relevant.2 The primary end point 
was significant, with skin Na+:K+ increasing between the pla-
cebo and slow sodium phases for the whole study population, 
but in our study, this appeared to be mainly driven by men.
Our measurements show that women have lower skin K+ 
and consequently a higher Na+:K+ ratio (Table 1). The epi-
dermis has a significant K+ content, and this difference could 
be explained by the epidermis being thinner in women.21,22 
Therefore, changes in Na+:K+ ratio with salt loading can be 
compared, but it is not possible to directly compare values 
for skin Na+:K+ between men and women. The use of contra-
ceptives appeared to influence skin K+ values (Table S2). The 
reasons for this are unclear although estrogen administration 
increases epidermal thickness.23 Importantly, women have the 
same response in skin Na+:K+ with salt loading regardless of 
contraceptive use (Table S2 and Figure S5).
Previous human data on skin electrolytes are sparse. Oral 
salt loading experiments conducted over 80 years ago, in a small 
number of humans, showed that 10 g NaCl administered daily 
for 1 week increased the Na+ content of human skin by 15% to 
20%, suggesting the skin was a repository for NaCl.24 Direct 
chemical measurements in human skin, performed >70 years 
ago, yielded values of between 1.00 to 2.14 mg/g for Na+ and 
0.64 to 0.91 mg/g for K+ per wet weight of skin.25–27 Our values 
for Na+ and K+ fell within this range but are difficult to compare 
with skin Na+ measured using MRI, which are expressed as 
mmol/L of water.14,16 Elemental measurements per wet weight 
of tissue may have potential inaccuracies introduced by changes 
in sample hydration during sample processing, which is why 
previous animal studies expressed skin Na+ and K+ concentra-
tions per unit dry weight after dry ashing.11,19,20 Our samples 
had an average wet weight of ≈15 mg compared with rat skin 
samples (≈60 g) and, unfortunately, were not suitable for dry 
ashing. Because our freeze-drying technique could not remove 
moisture uniformly in small samples, we corrected for sample 
hydration by expressing skin Na+ as a ratio Na+:K+ because of 
our ability to measure K+ reliably with ICP-OES and evidence 
from animal work that skin K+ remains stable with extremes of 
salt intake.11,19,20 Importantly, skin K+ did not change with salt 
Figure 1. Changes in skin Na+:K+ ratios between placebo and slow sodium phases. A, All 48 participants. B, 24 males. C, 24 females. The 
change in skin Na+:K+ between placebo and slow sodium for males and females, respectively, was analyzed using the Student paired t 
test. P<0.05 taken to be significant.
Table 1. Differences in Skin Biochemical Responses to Placebo vs Slow Sodium by Sex
Variable 
Men (n=24) Women (n=24)
Placebo Slow Sodium P Value Placebo Slow Sodium P Value
Skin Na+, mg/g 2.02±0.06 2.27±0.08 0.02 2.15±0.05 2.14±0.03 0.84
Skin K+, mg/g 0.80±0.03 0.82±0.04 0.59 0.68±0.03 0.65±0.02 0.28
Skin Na+:K+ 2.59±0.09 2.88±0.12 0.008 3.23±0.10 3.36±0.12 0.31
Women have a lower skin K compared with men (P<0.01 post-placebo and slow sodium) and consequently have 
higher Na+:K+ ratio than men (P<0.001 post-placebo and salt).
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loading. Furthermore, the Na+ content of injected local anes-
thetic did not seem to contaminate our skin samples (Methods 
in the online-only Data Supplement; Figure S4).
In our post hoc analyses, skin Na+:K+ differed between men 
and women after placebo and slow sodium, and it appeared 
that skin Na+:K+ rose with salt loading in men but not in 
women. Although this sex difference failed to achieve signifi-
cance with formal ANOVA comparison, no doubt because of 
the small sample size, it is potentially interesting. Women had 
a significant increase in day and night ambulatory BP while 
men did not. This was associated with significant weight 
gain in women, in keeping with previous data demonstrating 
greater sensitivity to dietary sodium in women.28–30 Baseline 
sex differences in hemodynamic and biochemical variables 
were also in keeping with previous studies in healthy young 
adults.31–35 Augmentation index is higher in women, and this 
is thought to be because of women having shorter stature and 
higher PVR when corrected for body surface area.33,36 Our 
study was not powered to show a sex difference in PVR or 
pulse wave velocity. There could be several explanations for 
the sex differences observed with salt loading.
The reason for observed sex difference in salt sensitivity is 
unclear, and the importance of addressing this issue has been 
highlighted recently.3,4 In our study, there was a modest, but 
Table 2. Differences in Hemodynamic Responses to Placebo vs Slow Sodium by Sex
Variable 
Males (n=24) Females (n=24)
Placebo Slow Sodium P Value Placebo Slow Sodium P Value
Body weight, kg 73.6±2.5 73.6±2.5 0.93 63.5±1.6 64.2±1.6 0.01*
Office measurements
  Seated SBP, mm Hg 120±2 119±2 0.85 114±2 114±2 0.72
  Seated DBP, mm Hg 71±2 71±2 0.98 73±2 73±1 0.75
  Seated MAP, mm Hg 87±1 87±2 0.65 87±2 88±1 0.43
  Seated HR, bpm 72±2 68±2 0.12 74±2 72±2 0.30
  Supine SBP, mm Hg 116±2 116±4 0.91 111±2 113±2 0.27
  Supine DBP, mm Hg 65±2 65±2 0.72 68±2 69±1 0.55
  Supine MAP, mm Hg 83±2 82±1 0.62 83±2 84±2 0.33
  Supine HR, bpm 60±2 58±2 0.15 64±2 63±2 0.23
Ambulatory BP, mm Hg
  24-h SBP 121±1 122±2 0.57 114±1 118±1 <0.001*
  24-h DBP 73±2 73±2 0.46 71±1 73±1 0.05
  24-h MAP 96±2 96±2 0.89 91±1 93±1 <0.001*
  Day SBP 124±1 125±2 0.32 118±1 121±2 0.02*
  Day DBP 76±2 76±2 0.34 75±2 76±2 0.33
  Day MAP 98±2 98±2 0.93 95±1 97±2 0.05
  Night SBP 114±2 115±2 0.52 105±1 110±1 <0.001*
  Night DBP 65±2 66±2 0.65 63±1 65±1 0.01*
  Night MAP 88±2 89±2 0.80 82±1 86±1 <0.001*
Central hemodynamics
  CSBP, mm Hg 99±1 99±2 0.99 95±2 98±2 0.11
  CDBP, mm Hg 67±2 66±2 0.21 69±2 70±1 0.22
  CMAP, mm Hg 82±2 80±2 0.12 83±2 85±2 0.22
  Augmentation index, % 4.5±2 4.5±2 0.98 13.7±3 14.5±3 0.58
  PWV ms−1 5.2 (4.7–5.6) 5.3 (4.9–6.0) 0.10 5.0 (4.7–5.5) 5.2 (4.8–5.4) 0.93
  Cardiac output, L/min 6.6±0.3 7.0±0.4 0.08 5.6±0.3 5.8±0.3 0.10
  Stroke volume, mL 107.9±5.2 116.8±6.5 0.09 86.0±4.0 88.9±3.6 0.29
  PVR, dynes s−1 cm−5 1048±51 1045±64 0.57 1251±72 1212±66 0.46
Normally distributed data are presented as mean±SEM. Non-normally distributed data are presented as median and 
interquartile range. BP indicates blood pressure; CDBP, central diastolic BP; CMAP, central mean arterial pressure; CSBP, central 
systolic BP; DBP, diastolic blood pressure; HR, heart rate; MAP, mean arterial pressure; PVR, peripheral vascular resistance; 
PWV, pulse wave velocity; and SBP, systolic blood pressure.
*P value is statistically significant.
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statistically significant difference in 24-hour UNaV, where 
women were lower than men post-placebo, suggesting that 
women were either more adherent to a low-salt diet or simply 
ate less. This difference was statistically significant but mod-
est. There are known limitations of using 24-hour UNaV to 
estimate Na+ intake, with recent evidence showing ±25 mmol 
deviations in urinary Na+ from recorded Na+ intake.37 An alter-
native explanation is that BP in men did not change with a 
short-term changes in salt intake because they could buffer 
the additional dietary Na+ with their skin via mechanisms 
described in animal studies while in women, this ability was 
attenuated.
Table 3. Differences in Biochemical Responses to Placebo vs Slow Sodium by Sex
Variable 
Males (n=24) Females (n=24)
Placebo Slow Sodium P Value Placebo Slow Sodium P Value
Serum measurements
  Na+, mmol/L 140±0.4 141±0.3 0.001* 139±0.3 140±0.4 <0.001*
  Cl−, mmol/L 103±0.4 106±0.5 <0.001* 103±0.4 105±0.6 <0.001*
  K+, mmol/L 4.4±0.06 4.4±0.07 0.97 4.3±0.07 4.3±0.09 0.69
  eGFR, mL/min per 1.72 m2 114.7 (103.9–127.5) 117.1 (107.3–136.7) 0.24 99.2 (84.1–119.2) 105.9 (94.2–127.8) <0.001*
Plasma measurements
  Renin, mU/L 24 (15–30) 11 (4–13) <0.001* 17 (9–21) 3 (2–7) <0.001*
  Aldosterone, pmol/L 221 (143–318) 80 (69–111) <0.001* 240 (137–435) 69 (69–75) <0.001*
  VEGF-C, pg/mL 540 (352–881) 625 (460–1066) 0.20 830 (467–1404) 755 (412–1130) 0.39
  sFLT-4, pg/mL 8.9±1.1 9.1±1.0 0.79 10.3±1.0 10.6±0.9 0.57
Urinary measurements
  Volume, mL/24 h 1540±174 1678±203 0.25 1935±166 2299±186 0.004*
  Na+, mmol/24 h 86.3±10.3 221.9±16.5 <0.001* 60.0±6.8 227.1±19.9 <0.001*
  Cl−, mmol/24 h 103.7±11.6 228.1±14.4 <0.001* 83.8±8.2 241.3±21.5 <0.001*
  K+, mmol/24 h 63.3 (51.2–93.5) 55.1 (39.9–73.8) 0.15 56.9 (40.5–76.7) 58.7 (41.6–77.9) 0.49
  Creatinine clearance, mL/min 111.1±9.1 125.3±9.6 0.14 108.1±8.0 122.4±7.6 0.06
  Fractional excretion
Na
, % 0.44±0.06 0.93±0.08 <0.001* 0.28±0.03 0.94±0.09 <0.001*
Normally distributed data are presented as mean±SEM. Non-normally distributed data are presented as median and interquartile range. eGFR indicates estimated 
glomerular filtration rate; sFLT-4, soluble fms-like tyrosine kinase 4; and VEGF-C, vascular endothelial growth factor C.
*P value is statistically significant.
Figure 2. Correlation between skin Na+:K+ and haemodynamic variables in 24 male participants. A, Supine brachial mean arterial pressure 
(MAP) post-placebo. B, Stroke volume post-placebo. C, Peripheral vascular resistance (PVR) post-placebo. D, Supine brachial MAP post-
slow sodium. E, Stroke volume post-slow sodium. F, PVR post-slow sodium.
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In animals, the skin buffers dietary salt, and a lower capac-
ity to store Na+ in the skin is associated with a greater BP 
rise during acute salt loading.38 Recent evidence in humans 
suggests that the ability to store Na+ in the interstitium serves 
as a protective factor against the pressor effect of salt.30 Our 
results are consistent with these data albeit with a sex differ-
ence. We propose 2 reasons why the sex differences may have 
been observed. First, men have a thicker skin at all ages and 
may have higher levels of dermal glycosaminoglycans.39,40 
This could imply that the skin is a more effective buffer for 
dietary Na+ in men. Indeed, animal data demonstrate that with 
a high-salt intake, male rats have a higher capacity for osmoti-
cally inactive skin Na+ storage compared with fertile female 
rats.38 Second, comparison of skin Na+ measurements not 
corrected for differences in sample hydration, reveals a trend 
for women to have a higher skin Na+ post-placebo than men. 
This suggests that men had greater passage of Na+ through 
the skin than women rather than greater storage of skin Na+, 
and this passage of Na+ was protective in short-term salt load-
ing. As shown in animal studies, the passage of skin Na+ into 
the skin would have resulted in efflux of Na+ via VEGF-C–
mediated lymphangiogenesis, which relates to NO production 
by VEGF-C.10,11 This is consistent with the known adaptation 
of salt-resistant subjects to a salt load, which is vasodilation 
concomitant to the increase in cardiac output.30,41–43
We found significant correlations between skin Na+:K+ and 
various hemodynamic parameters in men, which were present 
regardless of salt intake. This suggests a physiological role for 
skin Na+ or Na+:K+ ratio in regulating normal hemodynamics. 
The negative correlation between skin Na+:K+ and stroke vol-
ume could reflect increased osmotically inactive Na+ binding 
to glycosaminoglycans, allowing Na+ without commensurate 
water accumulation and therefore a less pronounced rise in 
circulatory volume.44 The positive correlation between BP 
and Na+:K+ support recent 23Na MRI data, which showed a 
positive correlation between BP and skin Na+.14,15 The mecha-
nisms for these observations remain to be explained but could 
potentially involve interactions between hypoxia-inducible 
transcription factors, NO, and skin Na+. The skin is a rich 
source of NO, and the expression of NO is altered by hypoxia-
inducible transcription factors, which is in turn modulated by 
salt intake.13,45,46 This interaction could potentially modulate 
PVR and the resulting BP. Alternatively, dermal capillary rar-
efaction, which refers to a reduction in capillary blood flow 
and increase in PVR, is associated with increased dietary 
salt and hypertension in humans.47 These mechanisms could 
potentially explain the positive correlation between skin Na+ 
and BP, as well as PVR although, clearly, further studies are 
required. A distinction should be made between the role of 
skin Na+ in influencing BP in response to short- and long-term 
high-salt intake. In short-term salt loading, as in our study, der-
mal Na+ storage may buffer the BP response to salt. However, 
in the long term (months), the ability to maintain normal BP 
in the face of high-salt intake is dependent on the ability to 
decrease PVR.48 The positive correlation seen between skin 
Na+:K+ and PVR suggests that skin Na+ accumulation may, in 
the longer term, lead to higher BP by increasing PVR. This is 
supported by cross-sectional 23Na MRI data showing that skin 
Na+ storage higher in hypertensives.14 In women skin, Na+:K+ 
was positively correlated with PVR post-salt, but this was 
not independent of age. There was a trend for skin Na+:K+ to 
be lower in women on contraceptives. Therefore, the Na+:K+ 
ratio may have been less reliable for assessing correlations in 
women in our study.
We did not observe significant changes in plasma VEGF-C 
or sFLT-4 between placebo and slow sodium phases. A previ-
ous study looking at plasma VEGF-C in healthy adults noted 
no change on dietary salt loading.49 As far as we are aware, 
this was the first study to examine plasma sFLT-4. We did 
not measure skin VEGF-C levels and therefore cannot draw 
any conclusions on skin VEGF-C response. However, plasma 
VEGF-C in men correlated positively with skin Na+:K+ post 
sodium, suggesting that in the salt-loaded state, skin Na+ 
induced VEGF-C production, as seen previously in animal 
studies.10,11
This study has several limitations. The study size was 
small, but we used a state-of-the art technique to measure skin 
Na+, ICP-OES, which is more sensitive than 23Na MRI. Our 
participants were nonresident, and the control of Na+ intake 
was challenging, especially in men, most likely because of 
high salt levels in processed foods, which even highly moti-
vated participants would have struggled to avoid during the 
4-week study period.50 We could not normalize dietary Na+ 
intakes for body weight. Participants also did not have their 
K+ and calorie intakes strictly controlled. Women were not salt 
loaded on the same day of the menstrual cycle. Our skin biop-
sies were small, and we had no means of ascertaining whether 
they were representative of the whole skin or whether skin Na+ 
varies with time. We did not quantify glycosaminoglycans in 
our skin samples or show how much of this Na+ was osmoti-
cally inactive. We also could not measure Cl− with ICP-OES. 
A further limitation was that we performed post hoc analysis 
by sex, and this was because of unexpected sex differences in 
skin K+ and the consequent limitations of using the Na+:K+. 
The sex differences in BP and skin Na+ are interesting but war-
rant further investigation and confirmation in larger studies. 
Our study was not primarily designed to determine salt sensi-
tivity: it examined skin Na+ in response to changes in dietary 
Na+. Our target Na+ intake during the placebo phase was 70 
mmol, which is high compared with other studies examin-
ing salt sensitivity.28,29 The use of ambulatory BP monitoring 
Figure 3. Correlation between skin Na+:K+ and VEGF-C (vascular 
endothelial growth factor C) post-slow sodium in 24 male 
participants.
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made the detection of significant BP changes in women possi-
ble. Similar studies should also be conducted in older people, 
other ethnicities, and hypertensives. We conducted a short-
term study because salt loading during a longer period may 
not have been ethical and chronic skin electrolyte changes in 
response to changes in salt intake may be different. Despite 
these limitations, we were able to provide a unique insight into 
the influence of interstitial Na+ on the hemodynamic response 
to dietary salt and will inform further studies on skin Na+.
Perspectives
Worldwide, hypertension has a significant prevalence and asso-
ciated morbidity. An elevated BP is the single most important 
cause of cardiovascular disease, being responsible for 62% of 
strokes and 49% of coronary heart disease.51 Excessive salt 
intake is thought to play a crucial role in this epidemic.52 Our 
understanding of how salt affects BP and how we handle Na+ 
is lacking, and the traditional nephrocentric view of sodium 
and fluid balance provides an incomplete explanation for this 
phenomenon. Our study provides novel data on how skin Na+ 
is altered by dietary salt, influences systemic hemodynamics, 
and may influence the regulation of salt sensitivity in a sex-
specific manner.
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What Is New?
•	Skin Na+ increases with dietary salt loading in humans.
•	The skin may buffer dietary Na+, reducing the hemodynamic conse-
quences of increased salt. This may be influenced by sex.
•	Skin Na+ may influence blood pressure, stroke volume, and peripheral 
vascular resistance.
What Is Relevant?
•	Excessive salt intake is thought to play a crucial role in the develop-
ment of hypertension, but the exact mechanisms have not been fully 
elucidated.
•	Sex differences have been observed in the hemodynamic response to 
dietary salt, with some studies showing women have a greater blood 
pressure response to dietary salt modulation. This has still not been ex-
plained.
Summary
Skin Na+ is influenced by dietary salt and influences systemic he-
modynamics. It may influence the regulation of salt sensitivity in a 
sex-specific manner.
Novelty and Significance
